As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.


Figure S1. Relative mRNA expression levels of PPARs isoforms in human colon cancer cells.

Figure S2. PPAR dominant negative mutant and GW9662 antagonist of PPAR inhibit resveratrol-induced biological effect in metastatic colon cancer cells SW620.

Figure S3. Figure 4. RSV combination with Troglitazone, a PPAR agonist, increases colon cancer cell death.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.